The Assistance Fund (TAF) Neuromyelitis Optica Spectrum Disorder Fund

The Neuromyelitis Optica Spectrum Disorder Financial Assistance Program, offered by The Assistance Fund, provides financial aid for out-of-pocket costs including prescription drug assistance, health insurance premiums, therapy administration, and travel costs (ground transport, air, meals, hotel) to treatment centers or physicians. Eligibility requires being a U.S. citizen/permanent resident, diagnosed with the disease, prescribed an FDA-approved treatment with prescription coverage, and meeting financial criteria based on household income and size. The program is currently open for new patient enrollments.

Eligibility

Applicants must be U.S. citizens or permanent residents diagnosed with Neuromyelitis Optica Spectrum Disorder and prescribed an FDA-approved treatment covered by insurance. Eligibility also requires meeting financial criteria based on household income and size to receive assistance with copays, premiums, and medical travel.